| Name | Title | Contact Details |
|---|
The DHA is a joint, integrated Combat Support Agency that enables the Army, Navy, and Air Force medical services to provide a medically ready force and ready medical force to Combatant Commands in both peacetime and wartime. The DHA supports the delivery of integrated, affordable, and high quality health services to 9.5 million Military Health System beneficiaries and is responsible for driving greater integration of clinical and business processes across the MHS. The DHA oversees the delivery of health care services like the TRICARE Health Plan, pharmacy, public health, and health information technology. DHA carries out these operations using a global health care network of military and civilian medical professionals and more than 400 military hospitals and clinics. This network strengthens the delivery of health care to MHS beneficiaries by merging proven clinical and business practices and emphasizing the experience of the patient. Exciting changes are taking place as we are in the process of reorganizing how we manage the military`s medical centers, hospitals and clinics around the world, shifting administration and management responsibility for these facilities from the Army, Navy and Air Force to the Defense Health Agency. A single integrated system will support improvements to the readiness of our operational and medical forces to meet our missions around the world, while providing outstanding care to all of those who depend on us, on the battlefield and at home.
Isoflux Biomed is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
TriCore Reference Laboratories is a community-based, independent, clinical reference laboratory that provides full-service, state-of-the-art laboratory tests to health care professionals and their patients. Based in Albuquerque, N.M., with clients in New Mexico and across the US. TriCore offers more than 1,500 laboratory tests ranging from routine (such as cholesterol screens) to highly specialized (such as genetic testing). TriCore participates in scientific research through collaboration with the University of New Mexico and numerous national and international biotech firms.
Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer. Imagin`s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.
NeurogesX, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Foster City, CA. To find more information about NeurogesX, Inc., please visit www.neurogesx.com